EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:94563 - benzydamine
| Formula | C19H23N3O |
| Net Charge | 0 |
| Average Mass | 309.413 |
| Monoisotopic Mass | 309.18411 |
| SMILES | CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12 |
| InChI | InChI=1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3 |
| InChIKey | CNBGNNVCVSKAQZ-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | central nervous system stimulant Any drug that enhances the activity of the central nervous system. hallucinogen Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations and other alterations of mood and thinking. non-steroidal anti-inflammatory drug An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. local anaesthetic Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| benzydamine (CHEBI:94563) has role analgesic (CHEBI:35480) |
| benzydamine (CHEBI:94563) has role central nervous system stimulant (CHEBI:35337) |
| benzydamine (CHEBI:94563) has role hallucinogen (CHEBI:35499) |
| benzydamine (CHEBI:94563) has role local anaesthetic (CHEBI:36333) |
| benzydamine (CHEBI:94563) has role non-steroidal anti-inflammatory drug (CHEBI:35475) |
| benzydamine (CHEBI:94563) is a aromatic ether (CHEBI:35618) |
| benzydamine (CHEBI:94563) is a indazoles (CHEBI:38769) |
| benzydamine (CHEBI:94563) is a tertiary amino compound (CHEBI:50996) |
| benzydamine (CHEBI:94563) is conjugate base of benzydamine(1+) (CHEBI:134500) |
| Incoming Relation(s) |
| benzydamine(1+) (CHEBI:134500) is conjugate acid of benzydamine (CHEBI:94563) |
| IUPAC Name |
|---|
| 3-[(1-benzyl-1H-indazol-3-yl)oxy]-N,N-dimethylpropan-1-aminie |
| INNs | Source |
|---|---|
| bencidamina | ChemIDplus |
| benzydamine | ChemIDplus |
| benzydamine | KEGG DRUG |
| benzydaminum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 1-Benzyl-3-(3-(dimethylamino)propoxy)-1H-indazole | ChemIDplus |
| benzidamine | DrugCentral |
| benzindamine | DrugCentral |
| benzydamide | DrugCentral |
| N,N-dimethyl-3-[[1-(phenylmethyl)-3-indazolyl]oxy]-1-propanamine | DrugCentral |
| Citations |
|---|